CPHI

CHINA PHARMA HOLDINGS, INC. CPHI

NYSESmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 8 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Revenue

$948.3K

Quarter to Jun 30

Net income

$-1.46M

Quarter to Jun 30

Operating margin

-151.0%

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$134.5K total
CITADEL ADVISORS LLC
$82.8K+870.6%
TWO SIGMA SECURITIES, LLC
$23.5KNew
RENAISSANCE TECHNOLOGIES LLC
$9.9K+31.8%
JANE STREET GROUP, LLC
$9.2KNew
Ground Swell Capital, LLC
$7.0KNew
UBS Group AG
$2.1K+699.2%
EFG International AG
$260.0%
DANSKE BANK A/S
$10.0%
See all 8 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Operating Margin

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Debt/Equity

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/CPHI

Earnings Per Share

13fpro.ai/company/CPHI

Loading ratio trend…

CPHI key financials by period

Reported revenue, net income and operating margin by fiscal year, from CHINA PHARMA HOLDINGS, INC.'s annual filings on SEC EDGAR.

CHINA PHARMA HOLDINGS, INC. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$4.1M$-3.2M-78.2%
FY 2024$4.5M$-4.7M-101.3%
FY 2023$7.0M$-3.1M-39.3%
FY 2022$8.1M$-4.0M-43.8%
FY 2021$9.6M$-3.4M-29.7%
FY 2020$10.9M$-2.9M-23.7%
Source: CPHI filings on SEC EDGAR →

About CHINA PHARMA HOLDINGS, INC. (CPHI): stock profile, AI score and financials

CHINA PHARMA HOLDINGS, INC. (CPHI) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. CPHI is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 8 institutional filers currently hold this stock. Based on the latest XBRL financial filings (Q2 2026), CHINA PHARMA HOLDINGS, INC. reports quarterly revenue of $948.3K, net income of $-1.5M, an operating margin of -151.0%. Top institutional holders of CPHI by reported 13-F value include CITADEL ADVISORS, TWO SIGMA SECURITIES, RENAISSANCE TECHNOLOGIES, based on the most recent SEC filings. CPHI trades on the NYSE exchange and files with the SEC under CIK 1106644. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CPHI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for CHINA PHARMA HOLDINGS, INC. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1106644 →